Clinical Trial Update: PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FDG-PET guided small-volume accelerated immuno-chemoradiotherapy for locally advanced, unresectable non-small cell lung cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: TheraOp | Conditions: Stage III Non-small Cell Lung Cancer, Locally Advanced | Phase 2 | Status: RECRUITING